INTRAOPERATIVE FLUORESCENCE DIAGNOSIS OF PERITONEAL DISSEMINATION IN PATIENTS WITH GASTRIC CANCER

The study of diagnostic efficiency of intraoperative fluorescence diagnosis (IOFD) of peritoneal dissemination in patients with gastric cancer comparing with standard laparoscopy was performed in P.A. Hertsen MCRI (the branch of NMRRC). The study included 114 patients with verified diagnosis of gastri...

Full description

Bibliographic Details
Main Authors: E. A. Suleymanov, A. D. Kaprin, E. V. Filonenko, V. M. Homyakov, N. A. Grishin, L. I. Moskvicheva, A. N. Urlova
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2016-12-01
Series:Biomedical Photonics
Subjects:
Online Access:https://www.pdt-journal.com/jour/article/view/97
_version_ 1797883691049943040
author E. A. Suleymanov
A. D. Kaprin
E. V. Filonenko
V. M. Homyakov
N. A. Grishin
L. I. Moskvicheva
A. N. Urlova
author_facet E. A. Suleymanov
A. D. Kaprin
E. V. Filonenko
V. M. Homyakov
N. A. Grishin
L. I. Moskvicheva
A. N. Urlova
author_sort E. A. Suleymanov
collection DOAJ
description The study of diagnostic efficiency of intraoperative fluorescence diagnosis (IOFD) of peritoneal dissemination in patients with gastric cancer comparing with standard laparoscopy was performed in P.A. Hertsen MCRI (the branch of NMRRC). The study included 114 patients with verified diagnosis of gastric cancer stage III–IV. For IOFD the domestic medication alasens (the active agent – 5-aminolevulinic acid) was used orally at dose of 30 mg/kg body weight 3 h prior to the study procedure. As the result of fluorescence diagnosis 10 (6.9%) patients had peritoneal tumor dissemination verified morphologically and undetected by standard laporoscopy. The sensitivity of peritoneal revision for standard laparoscopy in patients with gastric cancer stage III–IV was 60.8%, the specificity – 75.8%, the overall accuracy – 69.1%. The sensitivity for IOFD in patients with gastric cancer stage III–IV was 91.1%, the specificity – 93.9%, the overall accuracy – 92.7%. Thus, fluorescence study allowed improving the specificity, the sensitivity and the overall accuracy of diagnostic test. In the trial IOFD had the maximal diagnostic value in patients with visually undetectable microdissemination in «whight» light and with solitary visible peritoneal foci (the average number of additionally detected metastatic lesions in one patient – 1.22 and 1.4, respectively). Moreover, in the case of fluorescence diagnosis the number of detected microfoci of peritoneal dissemination was showed to increase with enlargement of area of tumor invasion to gastric serosa (at average of 2.29 additionally detected lesions in one patient with serosal invasion more than 2 cm2). The obtained results confirm the perspective of use of fluorescence diagnosis for detection of peritoneal dissemination, determination of true tumor extent, staging of the tumor and also for adjustment of following treatment tactics for this group of patients.
first_indexed 2024-04-10T03:54:38Z
format Article
id doaj.art-18c5a7327aed4c3088d6f058cc7b4378
institution Directory Open Access Journal
issn 2413-9432
language Russian
last_indexed 2024-04-10T03:54:38Z
publishDate 2016-12-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj.art-18c5a7327aed4c3088d6f058cc7b43782023-03-13T07:12:30ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322016-12-015391810.24931/2413-9432-2016-5-3-9-1891INTRAOPERATIVE FLUORESCENCE DIAGNOSIS OF PERITONEAL DISSEMINATION IN PATIENTS WITH GASTRIC CANCERE. A. Suleymanov0A. D. Kaprin1E. V. Filonenko2V. M. Homyakov3N. A. Grishin4L. I. Moskvicheva5A. N. Urlova6Республиканский Онкологический Диспансер, Грозный, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, Россия Первый Московский государственный медицинский университет им. И.М. Сеченова, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияThe study of diagnostic efficiency of intraoperative fluorescence diagnosis (IOFD) of peritoneal dissemination in patients with gastric cancer comparing with standard laparoscopy was performed in P.A. Hertsen MCRI (the branch of NMRRC). The study included 114 patients with verified diagnosis of gastric cancer stage III–IV. For IOFD the domestic medication alasens (the active agent – 5-aminolevulinic acid) was used orally at dose of 30 mg/kg body weight 3 h prior to the study procedure. As the result of fluorescence diagnosis 10 (6.9%) patients had peritoneal tumor dissemination verified morphologically and undetected by standard laporoscopy. The sensitivity of peritoneal revision for standard laparoscopy in patients with gastric cancer stage III–IV was 60.8%, the specificity – 75.8%, the overall accuracy – 69.1%. The sensitivity for IOFD in patients with gastric cancer stage III–IV was 91.1%, the specificity – 93.9%, the overall accuracy – 92.7%. Thus, fluorescence study allowed improving the specificity, the sensitivity and the overall accuracy of diagnostic test. In the trial IOFD had the maximal diagnostic value in patients with visually undetectable microdissemination in «whight» light and with solitary visible peritoneal foci (the average number of additionally detected metastatic lesions in one patient – 1.22 and 1.4, respectively). Moreover, in the case of fluorescence diagnosis the number of detected microfoci of peritoneal dissemination was showed to increase with enlargement of area of tumor invasion to gastric serosa (at average of 2.29 additionally detected lesions in one patient with serosal invasion more than 2 cm2). The obtained results confirm the perspective of use of fluorescence diagnosis for detection of peritoneal dissemination, determination of true tumor extent, staging of the tumor and also for adjustment of following treatment tactics for this group of patients.https://www.pdt-journal.com/jour/article/view/97рак желудкаперитонеальная диссеминацияинтраоперационная флуоресцентная диагностика5-аминолевули-новая кислотафлуоресценция
spellingShingle E. A. Suleymanov
A. D. Kaprin
E. V. Filonenko
V. M. Homyakov
N. A. Grishin
L. I. Moskvicheva
A. N. Urlova
INTRAOPERATIVE FLUORESCENCE DIAGNOSIS OF PERITONEAL DISSEMINATION IN PATIENTS WITH GASTRIC CANCER
Biomedical Photonics
рак желудка
перитонеальная диссеминация
интраоперационная флуоресцентная диагностика
5-аминолевули-новая кислота
флуоресценция
title INTRAOPERATIVE FLUORESCENCE DIAGNOSIS OF PERITONEAL DISSEMINATION IN PATIENTS WITH GASTRIC CANCER
title_full INTRAOPERATIVE FLUORESCENCE DIAGNOSIS OF PERITONEAL DISSEMINATION IN PATIENTS WITH GASTRIC CANCER
title_fullStr INTRAOPERATIVE FLUORESCENCE DIAGNOSIS OF PERITONEAL DISSEMINATION IN PATIENTS WITH GASTRIC CANCER
title_full_unstemmed INTRAOPERATIVE FLUORESCENCE DIAGNOSIS OF PERITONEAL DISSEMINATION IN PATIENTS WITH GASTRIC CANCER
title_short INTRAOPERATIVE FLUORESCENCE DIAGNOSIS OF PERITONEAL DISSEMINATION IN PATIENTS WITH GASTRIC CANCER
title_sort intraoperative fluorescence diagnosis of peritoneal dissemination in patients with gastric cancer
topic рак желудка
перитонеальная диссеминация
интраоперационная флуоресцентная диагностика
5-аминолевули-новая кислота
флуоресценция
url https://www.pdt-journal.com/jour/article/view/97
work_keys_str_mv AT easuleymanov intraoperativefluorescencediagnosisofperitonealdisseminationinpatientswithgastriccancer
AT adkaprin intraoperativefluorescencediagnosisofperitonealdisseminationinpatientswithgastriccancer
AT evfilonenko intraoperativefluorescencediagnosisofperitonealdisseminationinpatientswithgastriccancer
AT vmhomyakov intraoperativefluorescencediagnosisofperitonealdisseminationinpatientswithgastriccancer
AT nagrishin intraoperativefluorescencediagnosisofperitonealdisseminationinpatientswithgastriccancer
AT limoskvicheva intraoperativefluorescencediagnosisofperitonealdisseminationinpatientswithgastriccancer
AT anurlova intraoperativefluorescencediagnosisofperitonealdisseminationinpatientswithgastriccancer